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Abstract— In this paper, we introduce the use of a person-
alized Gaussian Process (pGP) model to predict per-patient
changes in ADAS-Cog13 – a significant predictor of Alzheimer’s
Disease (AD) in the cognitive domain – using data from each
patient’s previous visits, and testing on future (held-out) data.
We start by learning a population-level model using multi-
modal data from previously seen patients using a base Gaussian
Process (GP) regression. The pGP is then formed by adapting
the base GP sequentially over time to a new (target) patient
using domain adaptive GPs [1]. We extend this personalized
approach to predict the values of ADAS-Cog13 over the future 6,
12, 18, and 24 months. We compare this approach to a GP model
trained only on past data of the target patients (tGP), as well as
to a new approach that combines pGP with tGP. We find that
this new approach (pGP+tGP) leads to significant improvements
in accurately forecasting future ADAS-Cog13 scores.
I. INTRODUCTION
Recently, the view on Alzheimer’s Disease (AD) diagnosis
has shifted towards a more dynamic process in which
clinical and pathological markers evolve gradually before
diagnostic criteria are met. Given the wide variability in data
available per subject, inherent per-person differences, and the
slowly changing nature of the disease, accurate prediction
of AD progression is a significant, difficult challenge. The
Alzheimer’s Disease Assessment Scale-cognition sub-scale
(ADAS-Cog) [2] is the most widely used general cognitive
measure in clinical trials of AD [3]. While it was developed
as an outcome measure for dementia interventions, its primary
purpose was to be an index of global cognition in response
to antidementia therapies. The ADAS-Cog assesses multiple
cognitive domains including memory, language, praxis, and
orientation [3]. Because ADAS-Cog has proven important for
target clinical assessments, in this paper we focus on a ma-
chine learning method that can successfully forecast the future
values of this score for previously seen subjects. Specifically,
we use the modified ADAS-Cog 13-item scale [2], which
includes all original ADAS-Cog items, with the addition of a
number cancellation task and a delayed free recall task, for a
total of 85 points. As in the parent instrument, higher scores
indicate greater severity. The purpose of these additional
items was to increase the number of cognitive domains and
range of symptom severity without a substantial increase in
the time required for administration.
One of the main challenges in clinical assessment of
subjects at risk of developing AD is the ability to accurately
Fig. 1: Personalized GPs. The population model is first trained
using all past visits data of N subjects (xTR, yTR), where the time
difference between two visits is 6 months. The model personalization
to the target subject (N+1) is then achieved by sequentially adapting
the model predictions of the future ADAS-Cog13 scores yt+1:t+4
(using the posterior distribution of GPs - fGP ), informed by the visits
data up to time step t. The shaded fields in the output represent the
time points for which no visit data is available for a given subject.
predict the future cognitive scores of interest for clinical trials,
for instance, which aim to find the most effective treatments
for AD. For this, an automated approach that could forecast
the future cognitive scores such as ADAS-Cog13 would bring
a great value for the assessment procedure, and has potential
to significantly improve the efficacy and efficiency of clinical
trials, which are typically lengthy and expensive. For example,
out of hundreds of clinical trials, costing billions of dollars,
fewer than 1% have proceeded to the regulatory approval stage
and none have managed to prove a disease-modifying effect
[4], [5]. More successes depend on an improved ability to
accurately identify subjects at early ages of the disease where
treatments are most likely to be effective. Thus, developing
models with improved ability to automatically predict subjects’
future AD-related metrics indicating disease progression – and
to do so as early as possible, especially before the emergence
of clinical symptoms – is an important step towards this
end. Furthermore, accurate prediction of symptom onset in
the time window of 6 to 24 months is critical to participant
selection and formation of clinical trials. Thus, having access
to accurate future estimates of the progression of cognitive
scores such as ADAS-Cog13 within this time-frame is of
great importance.
In this paper, we use data from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI)[6], and, specifically, the
dataset processed for the TADPOLE Challenge [4], to address
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the problem of forecasting ADAS-Cog13. These data are
highly heterogeneous and multi-modal, and include imaging
(MRI, PET), cognitive scores, CSF biomarkers, genetics,
and demographics (e.g. age, gender, race) [4]. Although the
heterogeneous nature of this dataset lends itself to building
powerful, informative multi-modal models, the dataset itself is
very sparse, with different combinations of features missing
for different subjects. Partial records are also missing for
roughly 80% of subjects [7]. Moreover, given the wide
variability in available data per subject, inherent per-person
differences, and the slowly changing nature of the disease,
accurate forecasting of cognitive decline and related measures
of disease progression is a significant and difficult challenge.
To tackle the challenges mentioned above, we focus on
machine learning models that can easily adapt to each
individual and perform forecasting of his/her cognitive score
ADAS-Cog13. More specifically, we investigate the effects
of the model personalization for the forecasting task using
the framework of Gaussian Processes (GP) [8]. This non-
parametric probabilistic framework offers great modeling
flexibility by providing not only the predictions of future cog-
nitive scores but also uncertainty in these predictions, which
enables better quantification of the forecasting performance.
For the forecasting task, we first employ the personalized
Gaussian Process model (pGP) [9] to simultaneously predict
ADAS-Cog13 scores four steps ahead in time, given previous
assessment data of target subjects (see Fig.1). We forecast
using a period of four time steps ahead (6, 12, 18, and
24 months) due to its relevance for clinical trials, as well
as because our analysis of the auto-correlations in ADAS-
Cog13 scores (based on TADPOLE data) revealed their strong
correlation (> 80%) within the used forecasting window.
We evaluate our approach on a cohort of 100 subjects from
the ADNI dataset to predict future ADAS-Cog13 scores of
target subjects using data from each subject’s previous visits.
We define a subject visit as data collected at a single time
point during ADNI. We start by learning a population-level
model using multi-modal data of previously-seen (source)
subjects using the base GP regression (sGP). Then, this model
is adapted sequentially over time to a new (target) subject
using the notion of domain adaptive GPs [10], [1]. We extend
this personalization approach, which we denote as pGP, for
the forecasting task by learning to predict ADAS-Cog13 up
to four steps ahead (24 months), and show that it outperforms
sGP on a large majority of target subjects. We also compare
this model with the GP model trained only on the data of
target subjects (tGP). Surprisingly, this model, trained with a
much smaller set of data, outperforms the sGP model and also
pGP on a number of subjects. To leverage this, we combine
the pGP and tGP models, and find that the combination of the
two achieves the best performance on the forecasting task.
II. RELATED WORK
Here, we briefly review related work on forecasting of
cognitive scores and clinical status for AD assessment, with
the focus on the ADNI dataset. Most existing approaches
(e.g., [11], [12], [13]) focus on modeling subjects based
on their clinical status (CS): cognitively normal (CN), mild
cognitive impairment (MCI) and Alzheimer’s Disease (AD).
However, the majority of these focus on modeling biomarkers
at the population level; for instance, estimating typical
trajectories of markers over the full course of the disease
to estimate current disease progress and progression rate
[11], [12]. Guerrero et al. [12] used mixed effects modeling
to derive global and individual biomarker trajectories for a
training population, which was later used to instantiate subject-
specific models for unseen subjects. Some of the modeling
techniques [12], [14], [11] require cohorts with known disease
onset and are prone to bias due to the uncertainty of the
conversion time.
When it comes to forecasting of clinical status, several
authors attempted predicting target scores for longer time
windows. For example, several recent works have explored
the use of multiple, multi-modal predictors in combination
with various machine learning techniques (e.g. SVMs, neural
nets, GPs, etc.) to predict conversion from MCI to AD for
various future time periods, e.g. from 1-5 years after baseline
assessment [15], [16]. Likewise, the BrainAGE framework
has been proposed for predicting MCI-AD conversion within
3 years of follow-up [17]. In addition, to predict conversion
within time windows of up to 2 years (short-term converter)
and 2-4 years (long-term converter), [18] proposed a stepwise
learning approach, where the learned model first predicts
whether a subject converts to dementia, or remains stable,
and then predicts the more likely progression window (short-
term or long-term conversion). More recently, [19] evaluated
different machine learning models in order to develop an
algorithm for a 3-year prediction of conversion to AD in
MCI and Pre-MCI subjects based only on non-invasive and
effectively collectible predictors.
However, most of these works attempted forecasting of
changes in subjects’ CS, which deals with a limited number
of future outcomes (i.e., either binary or a three-class). By
contrast, we aim to forecast ADAS-Cog13, defined on a more
fine-grained scale (85 levels), which poses a more challenging
machine learning problem. While in our recent work [9], we
investigated forecasting of ADAS-Cog13 along with other
scores (CDSRB, CS, and MMSE), we did so for one step
ahead (6 months). In this work, we attempt forecasting of up
to 24 months ahead by focusing on ADAS-Cog13.
III. FORECASTING WITH PERSONALIZED GPS
Notation. We consider a supervised setting, where X(s) =
{x(s)ns }Nsns=1 represents the multi-modal input features of Ns
subjects from the ADNI dataset used to train the population
model. The outcome score for each individual subject visit
is stored as y(s)ns = ADAS-Cog13
(s)
ns
∈ (0-85), and Y (s) =
{y(s)ns }Nsns=1. Furthermore, each subject is represented by data
pairs: {x(s)ns ,y(s)ns }, where x(s)ns = {x1, .., xt} contains the in-
put features up to visit t, and y(s)ns = {yw} the corresponding
scores for the future visits w=t+1:t+4. The total number of
visits is denoted by T . For notational convenience, we drop
dependence on ns, and use {x(s)t , y(s)w }t=1:T−1 as data pairs
for training the (population) forecasting model1. Since some
subjects missed certain visits and not all biomarkers were
recorded at every visit, we fill in their missing values using
their nearest available past visit; however, no data of future
visits is used in training.
Population-level GP. We first build the population-level
forecasting model using data of training (source) subjects
{X(s),Y (s)}. The goal of the forecasting model is to predict
a subject’s future ADAS-Cog13 score as output y(s)w from data
of previous visits, x(s)t and y
(s)
t . To this end, we use the auto-
regressive GP [20], which learns the following forecasting
function:
y(s)w = f
(s)(x
(s)
t ; y
(s)
t ) + 
(s)
t , (1)
where (s)t ∼ N (0, σ2s) is i.i.d. additive Gaussian
noise. Following the framework of GPs [8], we
place a prior on the functions f (s). This gives
rise to the joint prior p(Y (s)2:T |{X(s),Y (s)}1:T−1) =
N (Y (s)2:T |0,K(s)1:T−1), where the elements of K(s)1:T−1 =
k(s)({X(s),Y (s)}1:T−1, {X(s),Y (s)}1:T−1) are computed
using radial basis function (RBF) -isotropic kernel. The kernel
parameters θ were chosen to minimize the negative log-
marginal likelihood: − log p(Y (s)2:T |{X(s),Y (s)}1:T−1,θ).
Given data from the visit at time t of a new subject,
x
(s)
∗ = {x(s)t , y(s)t }, the population GP predictive distribution
provides the mean and variance forecasts of the cognitive
scores y(s)w as:
µ(s)w = k
(s)
∗
T
(K(s) + σ2sI)
−1Y (s) (2)
V (s)w = k
(s)
∗∗ − k(s)∗
T
(K(s) + σ2sI)
−1k(s)∗ , (3)
where k(s)∗ = k(s)(X(s),x(s)∗ ) and k(s)∗∗ = k(s)(x(s)∗ ,x(s)∗ ),
and the distribution mean is used as a point estimate of
target outputs. We denote µ(s)w = µ
(s)
w (x
(s)
∗ ) and V (s)w =
V (s)w (x
(s)
∗ ), and refer to this setting as sGP (source GP).
Personalized GP (pGP). We extend the approach of
domain adaptive GPs (DA-GP) [10], [1] to personalize the
population GP model to target subjects. This is achieved by
sequentially adapting the GP posterior for the test subject
using the data of his/her past visits, to forecast the future
ADAS-Cog13 scores y(p)w . This is achieved by using the
obtained posterior distribution of the source (population)
data and data of the target subject up to visit t, to obtain
a prior for the GP of the future data for the subject:
p(Y (p)w |{X(p),Y (p)}1:t,D(s),θ). This prior is used to cor-
rect the posterior distribution derived above to account for
the previously seen data of the target subject. Formally, the
conditional prior on the target subject data (given the source
data) is obtained by applying Eqs. (2–3) on {X(p),Y (p)}1:t
to obtain µ(p|s)
w
and V (p|s)w . Given the prior and a test input
x
(p)
∗ = {x(p)t , y(p)t }, the correct form of the adapted posterior
after observing the target subject data at visit t is:
1From t = T − 3 : T , we forecast only the remaining scores.
µ(p)w = µ
(s)
w + V
(p|s)
w
T
(V
(p|s)
1:t + σ
2
sI)
−1(Y (p)1:t − µ(p|s)1:t )
(4)
V (p)w = V
(s)
w − V (p|s)w
T
(V
(p|s)
1:t + σ
2
sI)
−1V (p|s)w , (5)
with V (p|s)w = k(s)(X(p),x(p)∗ ) − k(s)(X(s),X(p))T (K(s) +
σ2sI)
−1k(s)(X(s),x(p)∗ ). Eqs. (4–5) show that final forecast
by the pGP is the combination of the population-model
forecast, plus a correction term2. The latter shifts the mean
toward the distribution of the target subject and improves the
model’s confidence by reducing its predictive variance. Note
that we use the shared covariance function for simultaneous
forecasting of yw. Consequently, the model assigns the same
variance (V w) to each future forecast in w.
Target GP (tGP). We also build the GP model from the
observed data of the target subject (the same data used for
the adaption in the pGP). However, since this data set is of
insufficient size to learn the GP parameters – the GP would
easily overfit – we use the kernel parameters of the population
model (sGP). Unlike the sGP, whose covariance matrix is
fixed (learned from previously seen source subjects), the tGP
continually updates its covariance matrix as more past data (up
to t) of a target subject becomes available. Nevertheless, the in-
ference procedure remains the same. Formally, this is given by:
µ(t)w = k
(t)
∗
T
(K
(t)
1:t + σ
2
sI)
−1Y (t)1:t (6)
V (t)w = k
(t)
∗∗ − k(t)∗
T
(K
(t)
1:t + σ
2
sI)
−1k(t)∗ . (7)
For exact derivation of the model equations, see [10], [1].
IV. RESULTS
Data used in this study were collected from the ADNI
database (adni.loni.usc.edu). We downloaded the standard
dataset processed for the TADPOLE Challenge [4]; this
dataset represents 1,737 unique subjects and was created
from the ADNIMERGE spreadsheet, to which regional MRI
(volumes, cortical thickness, surface area), PET (FDG, AV45,
AV1451), DTI (regional means of standard indices) and
cerebrospinal fluid (CSF) biomarkers were added. From this
data, we use all features provided except for clinical status
(CS) and normalized
ventricle volumes (ICVn)3, to construct a multi-modal
feature set consisting of six modalities: demographics (6
features), genetics (3 features), cognitive tests (9 features),
CSF (3 features), MRI (365 features), and DTI (229 features).
Due to sparseness, we excluded PET data entirely. However,
in the future, we plan to extend this work and incorporate
all three predictors (ADAS-Cog13, CS, and normalized
ventricular volume). In the experiments reported, we used a
cohort of 100 subjects with more than 10 visits and missing
no more than 82.5% of the features.
To evaluate performance, we ran a 10-fold subject-
independent cross-validation. All the input features were
2For t=1, the population model is used instead.
3In the TADPOLE Challenge, AdasCog-13, CS and ICVn are treated as
target outputs, so in this work we excluded the latter two, and other cognitive
scores (CDRSB and MMSE) as predictors in our model.
z-normalized (zero mean, unit variance). As performance
metrics, we report the mean absolute error (MAE) and
weighted error score (WES), as suggested by the TADPOLE
challenge [4]. MAE is the standard measure for regression
models and purely measures accuracy of prediction ignoring
confidence. However, we also exploit the confidence in
each prediction, as this is commonly used when evaluating
forecasting models. Thus, we report WES, which incorporates
the confidence estimates for the prediction into the score.
We compute WES using the 50% confidence intervals (CI)
obtained from the predictive distribution of the GPs as
CI = [µw±0.67(Vw)1/2] [4]. Note that we used the imputed
values (i.e., ADAS-Cog13 scores) for the missing visits to
form the equally spaced visits (6,12,18 and 24 months), but
the reported errors are computed on the existing visits only.
We report the results obtained using the following four
model variations: GP models learned from source subjects
only (sGPs), personalized versions of population-level GP
models (pGPs), and the GP models learned using only data
of target subjects (tGPs) up to time t. Since we found that
tGP performed very well (via a validation on source subjects
mimicking the forecasting task), we defined a joint GP model
that combines the personalized approach with target subject
data (pGP + tGP). We experimented using variance-based
weighting as in distributed GP approaches [21], [1]. However,
tGP tended to overestimate the variance due to the small
amount of per-person data used to build this model. By
averaging the pGP and tGP forecasts, we obtained the best
performance. Since both pGP and tGP provide a Gaussian
predictive distribution, the distribution of the average model
is also Gaussian N ( 12 (µ(p)w + µ(t)w ), 14 (V (p)w + V (t)w )). All
GP models were trained using GP toolbox [8].
In Fig. 2, we compare the trend of average MAE among
the four models, evaluated up to the 5th, 10th, 15th, and
21st visits, across four time steps. Generally, MAE for sGP,
pGP and pGP+tGP models follows a decreasing trend, with
sGP having the highest error, and pGP outperforming tGP
as more visits’ data become available. The joint pGP+tGP
model tends to mirror this error trend and mirrors the error
magnitude of tGP. Essentially, the joint model inherits the
lower error rate of tGP and the general trend of decreasing
error with visit number of pGP, which explains its best overall
performance, relative to the other models. We also observe a
crossover of pGP+tGP with pGP and tGP for t+1 time step.
For t+ 1 time step, pGP initially performs worse relative to
pGP+tGP; however, pGP outperforms the joint model after 17
visits (see Fig. 2a). This also reflects the fact that, for subjects
for whom the input features are very different from source
subjects (a large covariate shift), the adaptation approach
(pGP) is not very effective, and using tGP results in better
individual performance. However, our results demonstrate
that using the combination of the two is most effective.
Table 1 compares the error metrics for the four models
across four time steps. While pGP performs better at earlier
time steps, tGP dominates at later time steps. This is expected;
as more data of a target subject is available, tGP becomes
more consistent in its predictions on the target subject. Again,
(a) (b)
(c) (d)
Fig. 2: Line graphs showing trend of average MAE of each model
and time step, evaluated up to 5th, 10th, 15th, and 21st visits.
by combining pGP and tGP into a joint model, we achieve the
best overall performance in terms of MAE. In addition, from
the WES scores computed using the estimated variance of
the forecasts, we note that both sGP and pGP produce more
confident forecasts compared to tGP, which is a consequence
of a small set of data being used to compute the covariance
function of the tGP model.
In Fig. 3, we compare the results of the four models
and report the average results for each forecasting step.
Specifically, in Fig. 3a, we compare the sGP with the joint
pGP+tGP model. We see that the combined pGP+tGP model
improves per subject performance largely, when compared to
the sGP model alone. Likewise, comparing this joint model
with only the target model (pGP), as shown in Fig. 3b, we
see the difference in performance is also pronounced. Finally,
from Fig. 3c we see the joint model outperforms the target
model (tGP) for around half of the subjects. This improvement
in performance (as can also be seen from Table 1) is due to
the personalization and learning of the target GPs, compared
to learning the GP from source subjects only.
TABLE I: Comparison of the proposed forecasting GP models. We
report mean±SD of the 10-fold person independent cross-validation
of the models, and for each forecasting step. The statistically
significant differences (the paired t-test with p = 0.05) between the
two best performing models at the time are marked with *.
Models MAE
t+ 1 t+ 2 t+ 3 t+ 4 Avg.
sGP 3.86±0.37 4.39±0.52 4.72±0.44 5.04±0.62 4.50±0.66
pGP 3.71±0.30* 4.05±0.29 4.54±0.36 4.40±0.56 4.18±0.51
tGP 4.31±0.56 4.00±0.40 4.63±0.38 4.17±0.49 4.28±0.52
pGP + tGP 3.76±0.42 3.72±0.28* 4.33±0.35* 3.88±0.40* 3.92±0.44*
WES
sGP 3.63±0.42 4.09±0.49 4.62±0.69 4.57±0.66 4.23±0.70
pGP 3.62±0.41* 3.99±0.42 4.57±0.68 4.39±0.64 4.14±0.66
tGP 4.14±0.41 3.99±0.35 4.77±0.62 4.11±0.52 4.25±0.57
pGP + tGP 3.65±0.55 3.63±0.28* 4.38±0.58* 3.86±0.46* 3.88±0.57*
(a) (b) (c)
Fig. 3: Each subject’s average MAE over the forecasting window w = {6, 12, 18, 24} months. We contrast the joint pGP+tGP model
against (a) sGP, (b) pGP, and (c) tGP, respectively. The subjects are sorted based on the increasing MAE of the pGP+tGP model.
V. CONCLUSIONS
This work developed two variants of personalized GP
models, both customized for the challenging task of simul-
taneously predicting four ADAS-Cog13 scores, at 6, 12, 18,
and 24 months into the future. We tested these models
on a cohort of 100 ADNI subjects, showing significant
improvements over population-level GP models. Furthermore,
we showed that by combining the personalized GP models
(that use domain adaptation techniques) and subject-specific
GP models, we achieve the best forecasting performance
overall. This personalized forecasting framework enables
prediction of changes in AD-related cognitive scores as early
as possible, up to 24 months in the future, using a minimal set
of subject data. This capability is of great importance to both
clinicians and those at risk of AD since it is critical to early
identification of at-risk subjects, construction of informative
clinical trials, and timely detection of AD.
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